查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球眼科激光市場：到 2028 年的預測——按產品、應用、最終用戶和地區分析
市場調查報告書
商品編碼
1218882

全球眼科激光市場：到 2028 年的預測——按產品、應用、最終用戶和地區分析

Ophthalmic Lasers Market Forecasts to 2028 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2022 年全球眼科激光市場規模將達到 13.7507 億美元，預計到 2028 年將達到 20.2914 億美元，預測期內復合年增長率為 6.7%。眼科激光是能夠精確治療各種眼部問題且幾乎沒有感染風險的工具。許多激光手術可以在沒有麻醉的情況下進行，而且疼痛很小。眼科激光由於其安全性、準確性和相對經濟性的結合而成為眼科領域特別有用的儀器。激光控制台、腳踏板和激光傳輸系統是激光系統的三大要素。可以使用通過光纖電纜連接到控制台的各種傳輸設備將激光能量傳輸到患者的眼睛。

研究發現，女性在兒童時期患近視的可能性比男性高 24%，但成年後患近視的可能性低 12%。其原因不明，但可能是由於荷爾蒙的變化和男女生活方式的差異。

市場動態

促進者

眼科疾病的患病率

屈光不正、年齡相關性黃斑變性、白內障、糖尿病性視網膜病變和青光眼等眼科疾病的全球患病率上升是推動眼科激光市場增長的關鍵因素之一。此外，眼科微創手術和技術創新的趨勢推動了眼科激光設備市場的需求。此外，保持適當眼睛健康的需求不斷增加，這將推動全球眼科激光市場的增長。

抑製劑

替代療法的可用性

視力矯正替代療法的可用性預計將阻礙眼科醫用激光市場。眼科學中的激光替代療法包括使用晶狀體進行視力矯正，使用諸如有晶狀體眼人工晶狀體植入物和屈光晶狀體置換手術等技術。美國白內障和屈光手術學會 (ASCRS) 的統計數據證實，選擇標准人工晶狀體手術（白內障手術被認為是安全的）的患者可以完全恢復視力。因此，視力矯正替代療法的可用性預計會阻礙眼科醫用激光市場。

機會

眼科激光治療眼病的效率

年齡相關性青光眼、白內障、近視和其他眼病影響著許多患者，尤其是老年人。藥物治療對某些眼病的療效一般，這就是眼科激光等治療眼病的醫療器械市場不斷增長的原因。世界衛生組織估計，全世界有 1800 萬人因白內障而雙眼失明。此外，近視、極度近視、老花眼等屈光問題患者較多，市場機會廣闊。

威脅

成本高

由於醫務人員監管不力，發生了很多不幸事件，這削弱了用戶的信任。例如，直視強光引起的事故可能導致不可逆的眼睛損傷以及部分或完全失明。如果激光束擊中未受保護的眼睛，也會造成傷害。同樣，有一份名單列出了那些經常不願接受這種待遇的人，這些人共同代表了相當大一部分潛在客戶並阻礙了市場增長。

COVID-19 的影響

COVID-19 的爆發對眼科激光市場產生了相反的影響。在大流行期間，主要的醫療保健治療已被推遲，以減少冠狀病毒傳播的機會。在大流行期間，主要的健康治療已被推遲，以減少冠狀病毒傳播的機會。然而，由於 COVID 後放鬆管制，預計眼保健會有所增加。這些障礙正在影響眼科激光市場的增長。

飛秒激光細分市場預計將在預測期內成為最大的細分市場

飛秒激光部分估計有良好的增長；飛秒激光因為其極短的脈衝持續時間和紅外激光。由於脈衝持續時間短，飛秒激光器可以傳送激光能量，對周圍組織幾乎沒有附帶傷害。飛秒激光的優勢還在於它們可以照射角膜內部或下方的任何地方，並且可以部分穿過光學混濁介質，例如水腫角膜。支持市場增長。

白內障切除部分預計在預測期內表現出最高的複合年增長率

由於易於切割和晶狀體開口的激光碎裂，預計白內障切除術在預測期內將呈現最快的複合年增長率。與手工操作相比，此過程可產生更可靠、可重複和精確的切口。即使是熟練的外科醫生也無法製作出與激光相同精度的完美圓形開口。醫生之所以能夠這樣做，是因為激光可以進行精確可靠的切口，從而帶來更好、更可預測的視覺效果。因此，上述所有因素都在推動市場增長。

市場佔有率最高的地區

由於研發部門的發展、醫療改革的加強以及眼科領域的科學發展，亞太地區預計在預測期內將佔據最大的市場份額。亞太地區眼科激光市場的擴張主要是由於醫療保健基礎設施的改善以及配備最先進設備的醫院數量的增加。此外，眼科激光系統的技術進步和眼科診斷設備市場的擴大將進一步推動眼科激光製造商的市場增長。

複合年增長率最高的地區

歐洲在全球眼科激光器市場中佔有很大份額，預計在預測期內將保持這一主導地位，因此歐洲將成為預測期內復合年增長率最高的地區。其背景是眼科疾病患者數量的增加、對患者安全設備的需求增加、配備熟練醫務人員的最先進醫療設施的可用性以及研發活動的數量隨著重要公司的出現，政府對醫療保健系統的投資有所增加，從而推動了市場的增長。

重大發展

2022年12月，Novartis宣布將向絕經前和絕經後激素受體陽性、人類表皮生長因子受體2陰性（HR+/HER2？）晚期轉移性乳腺癌（MBC）患者，包括伴有內臟危象的患者率先宣布- Quiscari (R) (ribociclib) 聯合內分泌治療 (CT) 的 RIGHT 選擇 II 期試驗的結果。

2022 年 12 月，Novartis宣布 Pluvicto □（ INN ：櫓（177Lu）vipivotide tetraxetan）是一種靶向前列腺特異性膜抗原（ PSMA ）的放射配體治療藥物，在其關鍵的第三階段研究中達到了主要終點， PSMAfore 宣布。

2022 年 12 月，Johnson & Johnson Vision 宣佈在新加坡推出用於近視管理的 ACUVUE(R) Ability(TM) 1 天軟性治療鏡片，開始治療時 7 歲的每日佩戴一次性鏡片可能會減緩 12 歲以上兒童的近視進展歲。

2022年11月，Bosh Health宣布根據Bosh Health條款不受限制地使用Bausch + Lomb。因此，1261229 BC Ltd. 的所有子公司，包括 Bausch + Lomb 及其子公司，也已成為本公司的非限制性子公司，因此不再受 Bosch Health 債務文件項下契約的約束。

本報告內容

  • 區域和國家細分市場細分
  • 給新進入者的戰略建議
  • 涵蓋 2020、2021、2022、2025 和 2028 年的市場數據
  • 涵蓋市場趨勢（市場驅動因素、驅動因素、機遇、威脅、挑戰、投資機會、建議）
  • 基於市場估計的關鍵業務領域的戰略建議
  • 競爭格局映射關鍵共同趨勢
  • 公司概況，包括詳細戰略、財務狀況和近期發展
  • 映射最新技術進步的供應鏈趨勢

免費定制服務

訂閱此報告的客戶將免費獲得以下自定義選項之一。

  • 公司簡介
    • 其他市場參與者的綜合概況（最多 3 家公司）
    • 主要參與者的 SWOT 分析（最多 3 家公司）
  • 區域細分
    • 根據客戶要求對主要國家的市場估計、預測和復合年增長率（注：基於可行性檢查。）
  • 競爭標桿
    • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

目錄

第一章內容提要

第二章前言

  • 概述
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 研究來源
    • 主要研究來源
    • 二手研究資源
    • 假設

第三章市場趨勢分析

  • 促進者
  • 抑製劑
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5 全球眼科激光市場，按產品

  • 飛秒激光
  • 二極管激光器
  • 準分子激光
  • 其他產品

6. 全球眼科激光市場，按應用

  • 白內障摘除
  • 青光眼
  • 糖尿病性視網膜病變
  • 屈光不正矯正
  • 其他應用

7. 全球眼科激光市場，按最終用戶分類

  • 眼科
  • 醫院
  • 其他最終用戶

8.按地區分列的全球眼科激光市場

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東

第九章主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第十章公司簡介

  • Novartis AG
  • Bausch Health Companies Inc.
  • Topcon Corporation
  • Johnson & Johnson Surgical Vision Inc.
  • IRIDEX Corporation
  • Ziemer Opthalmic Systems AG
  • LIGHTMED
  • SCHWIND eye-tech-solutions
  • Lumenis
  • Lumibird Group
  • Carl Zeiss Meditec AG
  • NIDEK Co., Ltd.
  • Abbott Medical Optics Inc
  • Alcon Inc
Product Code: SMRC22418

According to Stratistics MRC, the Global Ophthalmic Lasers Market is accounted for $1375.07 million in 2022 and is expected to reach $2029.14 million by 2028 growing at a CAGR of 6.7% during the forecast period. Ophthalmic lasers are tools that enable precision therapy for a variety of eye issues with little danger of infection. Numerous laser operations can be done without anaesthesia and with little to no pain. Ophthalmic lasers are a particularly helpful instrument in the field of ophthalmology due to its combination of safety, accuracy, and relative affordability. The laser console, the foot pedal, and the laser delivery system are the three main elements of a laser system. The laser energy can be delivered to the patient's eye using a variety of delivery devices that are linked to the console by a fibre optic cable.

According to the study, women were 24% more likely than men to develop myopia as children, but they were 12% less likely to do so as adults. It's unclear why this is the case, but it could be because men and women endure different hormonal shifts or different lifestyles.

Market Dynamics:

Driver:

Prevalence of Ophthalmic Disorders

The rise in prevalence of ophthalmic disorders such as refractive errors, age-related macular degeneration, cataract, diabetic retinopathy and glaucoma, among others across the globe, is one of the major factors driving the growth of ophthalmic lasers market. Moreover, inclination towards minimally invasive procedures and innovations in ophthalmic will propel the demand in ophthalmic laser machines market. Further, growing need for maintaining proper eye health will drive growth in the global ophthalmic lasers market.

Restraint:

Availability of Alternative Therapies

The availability of alternative therapies for vision correction is expected to hinder the ophthalmic medical lasers market. The alternatives for lasers in ophthalmology include using a lens for correcting the vision using techniques such as Phakic Intraocular Lens Implants, and Refractive Lens Exchange Surgery. According to the statistics by the American Society of Cataract and Refractive Surgery (ASCRS), patients who choose to have a standard IOL procedure, which is considered safe for cataract surgery, experience fully restored vision. Therefore, the availability of alternative therapies to correct vision is expected to hamper the ophthalmic medical lasers market.

Opportunity:

Efficiency of ophthalmic lasers in the treatment of ocular diseases

Age-related glaucoma, cataract, myopia, and other eye illnesses affect a considerable patient base, particularly the older population. Because medications are only moderately effective in treating certain eye conditions, there is a growing market for medical devices, such as ophthalmic lasers, to treat eye conditions. The world health organization estimates that 18 million people worldwide are blind on both sides as a result of cataract. Additionally, a significant patient population experiences refractive problems like myopia, extreme myopia, and presbyopia which are providing wide range of opportunities to the market.

Threat:

High Cost

Numerous unfortunate circumstances caused by the poor supervision of medical professionals have occurred, undermining user confidence. For instance, accidents brought on by looking steadily into the light might irreversibly harm the eye and cause partial or complete blindness. Additionally, when a laser beam is projected into somebody's unprotected eyes, damage can result. Likewise, there is a list of persons who are frequently discouraged from receiving such therapies taken as a whole they represent a sizable portion of potential clients hindering the market growth.

COVID-19 Impact

The COVID-19 outbreak had a contradictory effect on the market for ophthalmic lasers. Significant healthcare treatments were postponed during the pandemic to decrease the likelihood of corona virus transmission. Major health treatments were postponed during the pandemic to reduce the chance of corona virus transmission. However, due to the easing of regulations after COVID, an increase in ophthalmic treatments is anticipated. Such hindrances are affecting the growth of the ophthalmic lasers market.

The femtosecond lasers segment is expected to be the largest during the forecast period

The femtosecond lasers segment is estimated to have a lucrative growth; due to their infrared laser with incredibly little pulse duration is the femtosecond laser. The femtosecond laser can deliver laser energy with little collateral harm to the surrounding tissue because of its brief pulse duration. The femtosecond laser is also exceptional in that it may be directed anywhere inside or below the cornea and can partially pass through optically cloudy media, like an edematous cornea which are boosting the market growth.

The cataract removal segment is expected to have the highest CAGR during the forecast period

The cataract removal segment is anticipated to witness the fastest CAGR growth during the forecast period, due to its ease on making incision and lens opening are made fragmented using a laser. This procedure produces a more dependable, reproducible, and exact incision than can be achieved by hand. Even a skilled surgeon cannot create a perfectly round aperture with the same level of precision as a laser. Doctors can do that because of the laser's accuracy and reliability in making incisions which leads to a better and more predictable vision outcome. Therefore, all the above factors are driving the market growth.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the development of the R&D sector, an increase in healthcare reforms, and scientific developments in the field of ophthalmology. Asia-Pacific ophthalmic lasers market, primarily as a result of improvements in the healthcare infrastructure, an increase in the number of hospitals with cutting-edge equipment. Furthermore, technological advancements in ophthalmic laser systems and expansion of ophthalmic diagnostic equipment market will further aid ophthalmic laser manufacturers to increase the growth of the market

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to a substantial share of the worldwide market for ophthalmic lasers, and it is anticipated that it will continue to hold this dominance during the forecast period. This is attributed to a rise in the number of ophthalmic disabilities, an increase in the demand for patient safety devices, the accessibility of cutting-edge healthcare facilities with skilled healthcare workers, an increase in the number of Research and development activities along with a notable presence of crucial players, and an increase in government investment in the healthcare system thereby propelling the market growth.

Key players in the market

Some of the key players profiled in the Ophthalmic Lasers Market include Novartis AG , Bausch Health Companies Inc, Topcon Corporation, Johnson & Johnson Surgical Vision Inc, IRIDEX Corporation, Ziemer Opthalmic Systems AG, LIGHTMED, SCHWIND eye-tech-solutions, Lumenis, Lumibird Group, Carl Zeiss Meditec AG, NIDEK Co., Ltd, Abbott Medical Optics Inc and Alcon Inc.

Key Developments:

In Dec 2022, Novartis announced results from the RIGHT Choice Phase II trial evaluating Kisqali® (ribociclib) plus endocrine therapy (ET) against combination chemotherapy (CT) in the first-line setting for pre- and perimenopausal patients with aggressive forms of hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2?) metastatic breast cancer (MBC), including patients with visceral crisis.

In Dec 2022, Novartis announced the pivotal Phase III PSMAfore study with PluvictoTM (INN: lutetium (177Lu) vipivotide tetraxetan), a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy, met its primary endpoint.

In Dec 2022, Johnson & Johnson Vision Announces Availability of ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management in Singapore, the daily wear, single-use, disposable lens has the potential to slow the progression of myopia in children who are 7 to 12 years old at the start of treatment.

In Nov 2022, Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Covenants. In connection therewith, all of the subsidiaries of 1261229 B.C. Ltd., including Bausch + Lomb and its subsidiaries, are also now unrestricted subsidiaries of the Company and, as a result, are no longer subject to the covenants under the Bausch Health debt documents.

Products Covered:

  • Femtosecond Lasers
  • Diode Lasers
  • Excimer Lasers
  • Other Products

Applications Covered:

  • Cataract Removal
  • Glaucoma
  • Diabetic Retinopathy
  • Refractive Error Corrections
  • Other Applications

End Users Covered:

  • Eye Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ophthalmic Lasers Market, By Product

  • 5.1 Introduction
  • 5.2 Femtosecond Lasers
  • 5.3 Diode Lasers
  • 5.4 Excimer Lasers
  • 5.5 Other Products

6 Global Ophthalmic Lasers Market, By Application

  • 6.1 Introduction
  • 6.2 Cataract Removal
  • 6.3 Glaucoma
  • 6.4 Diabetic Retinopathy
  • 6.5 Refractive Error Corrections
  • 6.6 Other Applications

7 Global Ophthalmic Lasers Market, By End User

  • 7.1 Introduction
  • 7.2 Eye Clinics
  • 7.3 Hospitals
  • 7.4 Other End Users

8 Global Ophthalmic Lasers Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Novartis AG
  • 10.2 Bausch Health Companies Inc.
  • 10.3 Topcon Corporation
  • 10.4 Johnson & Johnson Surgical Vision Inc.
  • 10.5 IRIDEX Corporation
  • 10.6 Ziemer Opthalmic Systems AG
  • 10.7 LIGHTMED
  • 10.8 SCHWIND eye-tech-solutions
  • 10.9 Lumenis
  • 10.10 Lumibird Group
  • 10.11 Carl Zeiss Meditec AG
  • 10.12 NIDEK Co., Ltd.
  • 10.13 Abbott Medical Optics Inc
  • 10.14 Alcon Inc

List of Tables

  • 1 Global Ophthalmic Lasers Market Outlook, By Region (2020-2028) ($MN)
  • 2 Global Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 3 Global Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 4 Global Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 5 Global Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 6 Global Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 7 Global Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 8 Global Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 9 Global Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 10 Global Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 11 Global Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 12 Global Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 13 Global Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 14 Global Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 15 Global Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 16 Global Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 17 North America Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 18 North America Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 19 North America Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 20 North America Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 21 North America Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 22 North America Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 23 North America Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 24 North America Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 25 North America Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 26 North America Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 27 North America Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 28 North America Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 29 North America Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 30 North America Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 31 North America Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 32 North America Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 33 Europe Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 34 Europe Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 35 Europe Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 36 Europe Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 37 Europe Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 38 Europe Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 39 Europe Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 40 Europe Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 41 Europe Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 42 Europe Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 43 Europe Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 44 Europe Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 45 Europe Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 46 Europe Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 47 Europe Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 48 Europe Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 49 Asia Pacific Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 50 Asia Pacific Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 51 Asia Pacific Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 52 Asia Pacific Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 53 Asia Pacific Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 54 Asia Pacific Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 55 Asia Pacific Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 56 Asia Pacific Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 57 Asia Pacific Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 58 Asia Pacific Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 59 Asia Pacific Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 60 Asia Pacific Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 61 Asia Pacific Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 62 Asia Pacific Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 63 Asia Pacific Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 64 Asia Pacific Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 65 South America Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 66 South America Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 67 South America Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 68 South America Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 69 South America Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 70 South America Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 71 South America Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 72 South America Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 73 South America Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 74 South America Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 75 South America Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 76 South America Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 77 South America Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 78 South America Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 79 South America Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 80 South America Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 81 Middle East & Africa Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 82 Middle East & Africa Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 83 Middle East & Africa Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 84 Middle East & Africa Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 85 Middle East & Africa Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 86 Middle East & Africa Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 87 Middle East & Africa Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 88 Middle East & Africa Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 89 Middle East & Africa Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 90 Middle East & Africa Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 91 Middle East & Africa Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 92 Middle East & Africa Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 93 Middle East & Africa Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 94 Middle East & Africa Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 95 Middle East & Africa Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 96 Middle East & Africa Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)